Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 8:02 pm Purchase | 2024-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | Redmile Group LLC | 13,932,449 9.900% | 10,155,602 (+268.89%) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | ORBIMED ADVISORS LLC | 13,135,260 9.900% | 13,135,260 (New Position) | Filing History |
| 2025-02-14 4:15 pm Purchase | 2024-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | PERCEPTIVE ADVISORS LLC | 5,880,000 4.500% | 3,740,050 (+174.77%) | Filing History |
| 2025-02-07 5:31 pm Sale | 2025-01-31 | 13G | RAPT Therapeutics, Inc. RAPT | The Vanguard Group | 2,932,399 2.220% | -223,606 (-7.09%) | Filing History |
| 2025-02-07 5:31 pm Sale | 2025-01-31 | 13G | RAPT Therapeutics, Inc. RAPT | The Vanguard Group | 2,932,399 2.220% | -223,606 (-7.09%) | Filing History |
| 2025-02-07 10:23 am Sale | 2025-01-31 | 13G | RAPT Therapeutics, Inc. RAPT | FMR LLC | 480,507 0.400% | -4,755,014 (-90.82%) | Filing History |
| 2025-01-06 6:38 pm Purchase | 2024-12-27 | 13G | RAPT Therapeutics, Inc. RAPT | BIOTECHNOLOGY VALUE FUND LP | 11,764,000 8.700% | 11,764,000 (New Position) | Filing History |
| 2025-01-06 09:22 am Purchase | 2024-12-27 | 13G | RAPT Therapeutics, Inc. RAPT | Medicxi IV LP | 22,352,000 16.900% | 22,352,000 (New Position) | Filing History |
| 2025-01-03 4:08 pm Purchase | 2024-12-27 | 13G | RAPT Therapeutics, Inc. RAPT | TCG Crossover GP II, LLC | 13,193,110 9.990% | 13,193,110 (New Position) | Filing History |
| 2024-12-30 3:32 pm Purchase | 2024-12-23 | 13G | RAPT Therapeutics, Inc. RAPT | Foresite Capital Fund VI LP | 12,500,000 9.300% | 12,500,000 (New Position) | Filing History |
| 2024-12-23 8:20 pm Sale | 2024-12-23 | 13D | RAPT Therapeutics, Inc. RAPT | COLUMN GROUP II LP | 1,603,593 4.900% | -2,821,846 (-63.76%) | Filing History |
| 2024-12-23 4:42 pm Purchase | 2024-12-23 | 13G | RAPT Therapeutics, Inc. RAPT | Deep Track Capital, LP | 14,116,000 9.870% | 14,116,000 (New Position) | Filing History |
| 2024-11-14 1:22 pm Sale | 2024-09-30 | 13G | RAPT Therapeutics, Inc. RAPT | PRICE T ROWE ASSOCIATES INC | 175,776 0.500% | -3,237,776 (-94.85%) | Filing History |
| 2024-11-14 09:39 am Sale | 2024-09-30 | 13G | RAPT Therapeutics, Inc. RAPT | Deep Track Capital, LP | 0 0.000% | -1,793,966 (Position Closed) | Filing History |
| 2024-11-12 4:59 pm Unchanged | 2024-09-30 | 13G | RAPT Therapeutics, Inc. RAPT | The Vanguard Group | 3,156,005 9.040% | 0 (Unchanged) | Filing History |
| 2024-11-12 10:34 am Purchase | 2024-11-08 | 13G | RAPT Therapeutics, Inc. RAPT | FMR LLC | 5,235,521 14.999% | 1,392,134 (+36.22%) | Filing History |
| 2024-11-04 1:30 pm Purchase | 2024-09-30 | 13G | RAPT Therapeutics, Inc. RAPT | The Vanguard Group | 3,156,005 9.040% | 1,099,784 (+53.49%) | Filing History |
| 2024-02-14 4:41 pm Purchase | 2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | PERCEPTIVE ADVISORS LLC | 2,139,950 6.200% | 340,995 (+18.96%) | Filing History |
| 2024-02-14 4:26 pm Purchase | 2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | Redmile Group LLC | 3,776,847 9.900% | 97,009 (+2.64%) | Filing History |
| 2024-02-14 10:03 am Sale | 2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | PRICE T ROWE ASSOCIATES INC | 3,413,552 9.900% | -142,910 (-4.02%) | Filing History |